PSCH Holdings Information

PSCH is an equity ETF with a total of 73 individual holdings. The top holdings are Glaukos stock at 5.53%, Corcept Therapeutics at 5.40%, Protagonist Therapeutics at 4.63%, Alkermes at 4.23%, and TG Therapeutics at 3.29%.

Total Holdings

Top 10 Percentage

37.66%

Asset Class

Equity

ETF Category

Health

Assets

190.24M

PE Ratio

28.36

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GKOS	Glaukos Corporation	5.53%	54,396
2	CORT	Corcept Therapeutics Incorporated	5.40%	88,509
3	PTGX	Protagonist Therapeutics, Inc.	4.63%	55,992
4	ALKS	Alkermes plc	4.23%	154,401
5	TGTX	TG Therapeutics, Inc.	3.29%	122,099
6	TFX	Teleflex Incorporated	3.04%	41,005
7	PTCT	PTC Therapeutics, Inc.	3.04%	76,843
8	LGND	Ligand Pharmaceuticals Incorporated	2.96%	18,570
9	LQDA	Liquidia Corporation	2.79%	65,063
10	RDNT	RadNet, Inc.	2.75%	65,558
11	MMSI	Merit Medical Systems, Inc.	2.74%	55,259
12	INDV	Indivior Pharmaceuticals, Inc.	2.38%	112,933
13	ICUI	ICU Medical, Inc.	2.26%	23,164
14	ITGR	Integer Holdings Corporation	2.14%	31,441
15	CON	Concentra Group Holdings Parent, Inc.	2.07%	110,233
16	ACAD	ACADIA Pharmaceuticals Inc.	1.88%	117,364
17	OGN	Organon & Co.	1.81%	243,235
18	VCYT	Veracyte, Inc.	1.80%	73,913
19	AMRX	Amneal Pharmaceuticals, Inc.	1.53%	159,571
20	TMDX	TransMedics Group, Inc.	1.52%	32,011
21	ACHC	Acadia Healthcare Company, Inc.	1.47%	85,194
22	WAY	Waystar Holding Corp.	1.42%	106,603
23	LFST	LifeStance Health Group, Inc.	1.41%	212,208
24	SUPN	Supernus Pharmaceuticals, Inc.	1.40%	53,752
25	NHC	National HealthCare Corporation	1.40%	11,582

Showing 25 of 73 holdings

Subscribe to see the full list

Activate Now

As of Aug 12, 2026